Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001437749-25-019188
Filing Date
2025-06-02
Accepted
2025-06-02 17:16:00
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-1 mbrx20250529c_s1.htm S-1 395839
2 EXHIBIT 1.1 ex_825648.htm EX-1.1 109154
3 EXHIBIT 4.12 ex_825649.htm EX-4.12 122054
4 EXHIBIT 4.13 ex_825650.htm EX-4.13 115770
5 EXHIBIT 5.1 ex_825964.htm EX-5.1 15342
6 EXHIBIT 10.35 ex_825651.htm EX-10.35 228347
7 EXHIBIT 23.1 ex_825963.htm EX-23.1 2293
8 EXHIBIT FILING FEES ex_825652.htm EX-FILING FEES 82391
9 ex_825964img001.jpg GRAPHIC 4159
10 ex_825964img002.jpg GRAPHIC 4159
  Complete submission text file 0001437749-25-019188.txt   1083900
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671997 | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-287727 | Film No.: 251016103
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)